Radiation exposure may flip a switch that helps trigger Alzheimer’s, researchers find

A review of more than 100 studies has identified a specific protein that radiation exposure pushes brain immune cells to release, and that protein goes on to trigger the same tau-tangling process seen in Alzheimer’s disease. Researchers at the Feinstein Institutes for Medical Research, part of Northwell Health, published the analysis Sept. 22, 2026, in Frontiers in Immunology, pooling data across occupational, medical, environmental, and space radiation exposures.

The paper puts a number on the risk: across a meta-analysis of 18 studies, every additional 100 millisieverts of cumulative radiation exposure tracked with an 11% rise in all-cause dementia risk. That dose is roughly what an airline crew member or a radiology technician might accumulate over a career, not what a single medical scan delivers, and the authors were careful to separate routine diagnostic imaging from the higher, repeated exposures their epidemiological data actually covers.

The eCIRP protein moves radiation damage into brain cells

Center for Immunology and Inflammation researchers Max Brenner, Archna Sharma, and Ping Wang, all at the Feinstein Institutes, describe a chain of events in their Frontiers in Immunology review that starts when ionizing radiation damages DNA and generates reactive oxygen species inside brain tissue. That damage triggers microglia — the brain’s resident immune cells — to release extracellular cold-inducible RNA-binding protein, known as eCIRP, into surrounding tissue and cerebrospinal fluid. eCIRP then activates a signaling cascade running through the IL-6 receptor and an enzyme called Cdk5, which adds phosphate groups to tau proteins in a pattern that mimics the tangles found in Alzheimer’s brains.

Wang has spent much of the past decade studying eCIRP as a driver of tissue damage in conditions far removed from dementia, including sepsis, hemorrhagic shock, and organ failure after trauma, work that established the protein as a marker of cellular stress the immune system releases when cells are injured. The September review is the first to extend that body of work into a specific neurodegenerative mechanism, arguing that the same alarm signal the body uses after a burn or a blood-loss injury also fires inside the skull after radiation damage and, over time, nudges brain proteins toward an Alzheimer’s-like state.

“Available evidence suggests that ionizing radiation can induce a temporal sequence of molecular and cellular changes leading to cognitive decline,” Wang’s team wrote in the review, tying together epidemiological, animal, and cell-level evidence that had previously been scattered across separate literatures on nuclear-industry workers, cancer patients, and astronauts.

A March mouse study already traced the same pathway

The mechanism was not new to the group. In a study the same lab published in March 2026 in Molecular Neurobiology, Wayne Chaung, Gaifeng Ma, Dmitriy Lapin, Sharma, Wang, and Brenner irradiated mice and measured eCIRP levels climbing 1.2-fold in blood serum and 2.6-fold in cerebrospinal fluid within 48 hours, alongside a matching spike in phosphorylated tau in the hippocampus. When the researchers blocked eCIRP using an inhibitor called C23, tau damage dropped; in mice genetically engineered to lack the CIRP gene entirely, hippocampal phosphorylated tau fell 59% compared with irradiated mice that still produced the protein.

Mice bred to already carry Alzheimer’s-like symptoms fared worse than ordinary mice once exposed to radiation, developing accelerated brain dysfunction on top of their existing pathology. Separate work the review cites found comparable tau and structural changes in irradiated monkeys, giving the human epidemiological signal a mechanistic backbone across two other species.

A write-up of the review noted that most of the animal and cellular evidence behind the eCIRP pathway used radiation doses well above anything a person encounters during ordinary medical care, a distinction the Feinstein Institutes team repeats to avoid implying that a single CT scan or dental X-ray carries meaningful dementia risk on its own.

Eighteen studies, five exposure groups, one dose-response curve

What distinguishes the September review from earlier radiation-Alzheimer’s speculation is that its 18-study meta-analysis spans five separate populations exposed under very different circumstances — atomic-bomb survivors, nuclear industry workers, radiotherapy patients, interventional radiology staff, and space-flight-adjacent cohorts — and still produced a consistent per-dose increase in dementia risk. A signal that shows up the same way across occupational, medical, and environmental exposure groups is harder to dismiss as confounding from any one industry or patient population.

Brenner’s Feinstein Institutes profile lists trauma, hemorrhagic shock, and inflammation among his broader research interests, and the eCIRP work traces back to earlier findings from the same center on the protein’s role in sepsis and organ injury before this review extended it into neurodegeneration. The Feinstein Institutes, founded in 1999 as the research arm of what is now Northwell Health, has built a research program around eCIRP for more than a decade.

The review stops short of recommending changes to medical imaging guidelines, and its authors note that most of the doses linked to elevated risk in their data came from repeated occupational or therapeutic exposure rather than the low, single-digit-millisievert doses typical of a chest X-ray or dental scan. What the paper adds is a specific, testable mechanism — one protein, one signaling pathway, one druggable target in C23 — where earlier studies had only an association between radiation history and later dementia diagnoses without an explanation for how one might cause the other.

This article was produced with the assistance of AI and reviewed by Morning Overview editors prior to publication.

More from Morning Overview